BioHarvest Sciences Inc. Files August 2025 6-K Report

Ticker: BHST · Form: 6-K · Filed: Aug 15, 2025

Sentiment: neutral

Topics: reporting, foreign-private-issuer, company-update

TL;DR

BHSC filed its August 6-K, confirming its foreign private issuer status and reporting from Canada.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on August 15, 2025, reporting for the month of August 2025. The company, formerly known as Midnight Star Ventures Corp. and CANNA-V-CELL SCIENCES INC., is incorporated in Canada and its principal executive offices are located in Vancouver, British Columbia. The filing indicates it is submitting its report under Form 40-F.

Why It Matters

This filing provides routine updates on BioHarvest Sciences Inc.'s activities as a foreign private issuer, which is important for investors tracking the company's compliance and reporting status.

Risk Assessment

Risk Level: low — This is a routine reporting form (6-K) that does not contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC for the month of August 2025, pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

What are the former names of BioHarvest Sciences Inc.?

BioHarvest Sciences Inc. was formerly known as CANNA-V-CELL SCIENCES INC. and Midnight Star Ventures Corp.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The company's principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

Which form does BioHarvest Sciences Inc. indicate it files annual reports under?

BioHarvest Sciences Inc. indicates it files annual reports under Form 40-F.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 205 words · 1 min read · ~1 pages · Grade level 17.9 · Accepted 2025-08-14 18:16:21

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: August 14, 2025 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing